価格表

在庫・価格 : 2025年04月25日 23時49分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
uPA, Human, ELISA Kit, AssayMax (96 well)
EU1001-1 ANGアッセイプロ
AssayPro
1 kit ¥77,000
(未発注)
追加

在庫・価格 : 2025年04月25日 23時49分 現在

uPA, Human, ELISA Kit, AssayMax (96 well)

  • 商品コード:EU1001-1
  • メーカー:ANG
  • 包装:1kit
  • 価格: ¥77,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Fujiuchi Y et al. (2003) Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol. Rep. 10(4):1001-1006

PubMed
2 Oka N et al. (2003) Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion. Eur Urol. 44(6):737-741

PubMed
3 Ueshima S et al. (2003) Suppression of the release of type-1 plasminogen activator inhibitor from human vascular endothelial cells by Hawaii deep sea water. Pathophysiology 9:103-109

PubMed
4 Fujiuchi Y et al. (2003) Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol. Rep. 10(4):1001-1006

PubMed
5 Oka N et al. (2003) Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion. Eur Urol. 44(6):737-741

PubMed
6 Uchima Y et al. (2004) Inhibition and Mechanism of Action of a Protease Inhibitor in Human Pancreatic Cancer Cells. Pancreas 29(2):123-131

PubMed
7 Yamaguchi Y et al. (2004) Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP). Am J Physiol Endocrinol Metab 287(5): E970-E976

PubMed
8 Nomuraa S et al. (2005) HMG-CoA Reductase Inhibitors Reduce Matrix Metalloproteinase-9 Activity in Human Varicose Veins. European Surgical Research 37(6):370-378

PubMed
9 Yamaguchi Y et al. (2005) Possible Involvement of Urokinase-Type Plasminogen Activator Release From Human Peripheral Blood Lymphocytes in the Pathophysiology of Chronic Allograft Nephropathy. Transplantation Proceedings. 37(10):4276-4281

PubMed
10 Cederqvist K et al. (2006) High Concentrations of Plasminogen Activator Inhibitor-1 in Lungs of Preterm Infants With Respiratory Distress Syndrome. Pediatrics 117(4):1226-1234

PubMed
11 Yang CC et al. (2007) In vitro regulation of adipogenesis: tunable engineered tissues. J Tissue Eng Regen Med. 1(2):146-153

PubMed
12 Yoshida C et al. (2007) Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells. Blood Coagulation & Fibrinolysis. 18(

PubMed
13 Ogura Y et al. (2008) Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. British Journal of Dermatology 159(1):49-60

PubMed
14 Okumura S et al. (2009) Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: Preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells. Clin Immunol. 130(2):175-185

PubMed
15 Grzmil M (2010) An oncogenic role of eIF3e/INT6 in human breast cancer. Oncogene. 29(28):4080-4089

PubMed
16 Rasheed SA et al. (2010) First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int J Cancer. 127(6):1475-1485

PubMed
17 Sutoh T et al. (2010) Nafamostat Mesilate (FUT-175) Inhibits Cell Growth and Invasion of Malignant Pleural Mesothelioma Cell Line, MSTO-211H. Hirosaki Med. J. 61:19-25

PubMed
18 Wyr?bska A et al. (2012) Comparison of Anti-Invasive Activity of Parthenolide and 3-Isopropyl-2-Methyl-4-Methyleneisoxazolidin-5-One (MZ-6) 繝サA New Compound with -Methylene--Lactone Motif 繝サon Two Breast Cancer Cell Lines. Chemical Biology & Drug Design 7

PubMed
19 Vieira ML et al. (2013) Interaction of Leptospira interrogans with Human Proteolytic Systems Enhances Dissemination through Endothelial Cells and Protease Levels. Infect Immun. 81(5):1764-74. doi: 10.1128/IAI.00020-13. Epub 2013 Mar 11

PubMed
20 Mahmoud AE and Ali MM (2014) Fermented Pomegranate (Punica granatum) Peel Extract as a Novel Anticancer Agent Targeting Angiogenesis and Metastasis. International Journal of toxicological and pharmacological research. 6(4):60-66

PubMed
21 Rashad MM et al. (2014) Production, characterization and anticancer activity of Candida bombicola sophorolipids by means of solid state fermentation of sunflower oil cake and soybean oil. Grasas Aceites 65 (2), e017. ISSN-L: 0017繝サ495 doi: http://dx.doi.o

PubMed
22 Rashad AE et al. (2015) Synthesis and anticancer evaluation of some fused pyrazolopyrimidines and their S-acyclic nucleosides. Der Pharma Chemica. 7(5):243-250

PubMed
23 Ekmek輅 OB et al. (2009) Effects of rhG-CSF Plus Dexamethasone on Hemostatic Parameters in Healthy Granulocyte Donors: Role of u-PA and Nitric Oxide. Clin. Appl. Thromb. Hemost. 15(6):689-694

PubMed
  • No.: 1
  • 文献情報:
    Fujiuchi Y et al. (2003) Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol. Rep. 10(4):1001-1006

  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Oka N et al. (2003) Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion. Eur Urol. 44(6):737-741

  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ueshima S et al. (2003) Suppression of the release of type-1 plasminogen activator inhibitor from human vascular endothelial cells by Hawaii deep sea water. Pathophysiology 9:103-109

  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Fujiuchi Y et al. (2003) Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol. Rep. 10(4):1001-1006

  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Oka N et al. (2003) Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion. Eur Urol. 44(6):737-741

  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Uchima Y et al. (2004) Inhibition and Mechanism of Action of a Protease Inhibitor in Human Pancreatic Cancer Cells. Pancreas 29(2):123-131

  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Yamaguchi Y et al. (2004) Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP). Am J Physiol Endocrinol Metab 287(5): E970-E976

  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Nomuraa S et al. (2005) HMG-CoA Reductase Inhibitors Reduce Matrix Metalloproteinase-9 Activity in Human Varicose Veins. European Surgical Research 37(6):370-378

  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Yamaguchi Y et al. (2005) Possible Involvement of Urokinase-Type Plasminogen Activator Release From Human Peripheral Blood Lymphocytes in the Pathophysiology of Chronic Allograft Nephropathy. Transplantation Proceedings. 37(10):4276-4281

  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Cederqvist K et al. (2006) High Concentrations of Plasminogen Activator Inhibitor-1 in Lungs of Preterm Infants With Respiratory Distress Syndrome. Pediatrics 117(4):1226-1234

  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Yang CC et al. (2007) In vitro regulation of adipogenesis: tunable engineered tissues. J Tissue Eng Regen Med. 1(2):146-153

  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Yoshida C et al. (2007) Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells. Blood Coagulation & Fibrinolysis. 18(

  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Ogura Y et al. (2008) Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. British Journal of Dermatology 159(1):49-60

  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Okumura S et al. (2009) Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: Preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells. Clin Immunol. 130(2):175-185

  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Grzmil M (2010) An oncogenic role of eIF3e/INT6 in human breast cancer. Oncogene. 29(28):4080-4089

  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Rasheed SA et al. (2010) First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int J Cancer. 127(6):1475-1485

  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Sutoh T et al. (2010) Nafamostat Mesilate (FUT-175) Inhibits Cell Growth and Invasion of Malignant Pleural Mesothelioma Cell Line, MSTO-211H. Hirosaki Med. J. 61:19-25

  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Wyr?bska A et al. (2012) Comparison of Anti-Invasive Activity of Parthenolide and 3-Isopropyl-2-Methyl-4-Methyleneisoxazolidin-5-One (MZ-6) 繝サA New Compound with -Methylene--Lactone Motif 繝サon Two Breast Cancer Cell Lines. Chemical Biology & Drug Design 7

  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Vieira ML et al. (2013) Interaction of Leptospira interrogans with Human Proteolytic Systems Enhances Dissemination through Endothelial Cells and Protease Levels. Infect Immun. 81(5):1764-74. doi: 10.1128/IAI.00020-13. Epub 2013 Mar 11

  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Mahmoud AE and Ali MM (2014) Fermented Pomegranate (Punica granatum) Peel Extract as a Novel Anticancer Agent Targeting Angiogenesis and Metastasis. International Journal of toxicological and pharmacological research. 6(4):60-66

  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Rashad MM et al. (2014) Production, characterization and anticancer activity of Candida bombicola sophorolipids by means of solid state fermentation of sunflower oil cake and soybean oil. Grasas Aceites 65 (2), e017. ISSN-L: 0017繝サ495 doi: http://dx.doi.o

  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Rashad AE et al. (2015) Synthesis and anticancer evaluation of some fused pyrazolopyrimidines and their S-acyclic nucleosides. Der Pharma Chemica. 7(5):243-250

  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Ekmek輅 OB et al. (2009) Effects of rhG-CSF Plus Dexamethasone on Hemostatic Parameters in Healthy Granulocyte Donors: Role of u-PA and Nitric Oxide. Clin. Appl. Thromb. Hemost. 15(6):689-694

  • 備考:
  • 参照:
    PubMed